Skip to Content

Ampicillin / sulbactam Pregnancy and Breastfeeding Warnings

Ampicillin / sulbactam is also known as: Unasyn

Ampicillin / sulbactam Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Ampicillin / sulbactam Breastfeeding Warnings

Candidiasis and diarrhea have been reported in an infant exposed to ampicillin via breast milk; causality unknown. Milk levels were 0.3 to 0.9 mg/L in 3 mothers who received ampicillin 2 g IM daily and 0.4 to 0.9 mg/L in 3 mothers who received 4 g IM daily. Peak milk levels were observed 3 hours postdose. It was estimated that the breastfed infant received 0.08 to 0.2 mg ampicillin daily with such doses. Milk ampicillin levels averaged 0.11, 0.21, 0.17, 0.27, and 0.26 mg/L at 30 minutes, 1 hour, 2 hours, 4 hours, and 6 hours after the dose, respectively, in 15 women receiving ampicillin 500 mg IM 4 times a day. Two hours after a single dose of ampicillin 2 g IV, milk levels averaged 1.1 mg/L. Milk was collected at random times after doses of sulbactam 0.5 or 1 g infused IV over 20 minutes. Milk levels averaged 0.52 mg/L during the first 8 hours postdose and the highest level was 2.8 mg/L; milk levels varied slightly over that period and there was little difference between the 2 doses. Levels obtained 10.5 to 20.5 hours postdose were 0.12 to 1.2 mg/L. In a study, postpartum women with endometritis received ampicillin 1 g plus sulbactam 0.5 g or ampicillin 2 g plus sulbactam 1 g infused IV over 20 minutes. Ampicillin milk levels averaged 1.7 mg/L and the highest level was 3 mg/L. Sulbactam milk levels averaged 0.58 mg/L and the highest level was 2.8 mg/L. Five nursing mothers reported taking oral ampicillin (dose not provided) in a prospective follow-up study. One mother reported diarrhea in her infant. Neither rash nor candidiasis was observed in exposed infants. During a small and controlled prospective study, mothers monitored their infants for signs of side effects (furring of the tongue, feeding difficulties, changes in stool frequency and consistency, diaper rash, skin rash), weight change, and jaundice. These parameters were not statistically different when infants of control mothers and of mothers taking oral ampicillin were compared.

Use is considered acceptable; caution is recommended. Excreted into human milk: Yes (both components in small amounts) Comments: -Low levels in milk are not expected to cause harmful effects in the nursing infant. -Ampicillin is considered compatible with breastfeeding by the WHO. -Sulbactam is considered compatible with breastfeeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. Lovett SM, Weiss JD, Diogo MJ, Williams PT, Garite TJ "A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy." Am J Obstet Gynecol 176 (1997): 1030-8
  2. "Product Information. Unasyn (ampicillin-sulbactam)." Roerig Division, New York, NY.

References for breastfeeding information

  1. Foulds G, Miller RD, Knirsch AK, Thrupp LD "Sulbactam kinetics and excretion into breast milk in postpartum women." Clin Pharmacol Ther 38 (1985): 692-6
  2. "American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk." Pediatrics 108 (2001): 776-89
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):
  4. Matheson I, Samseth M, Sande HA "Ampicillin in breast milk during puerperal infections." Eur J Clin Pharmacol 34 (1988): 657-9
  5. Department of Adolescent and Child Health and Development. UNICEF. World Health Organization "Breastfeeding and maternal medication: recommendations for drugs in the eleventh Who model list of essential drugs. Available from: URL:" ([2003]):
  6. Campbell AC, McElnay JC, Passmore CM "The excretion of ampicillin in breast milk and its effect on the suckling infant." Br J Clin Pharmacol 31 (1991): p230
  7. "Product Information. Unasyn (ampicillin-sulbactam)." Roerig Division, New York, NY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.